Session: OS2-101
Targeted drug delivery and Nanocarriers

Bernd Uhl (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany), Stephanie Hirn (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany), Roland Immler (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany), Karina Mildner (Electron Microscopy Unit, Max Planck Institute for Molecular Biomedicine, Münster, Germany), Leonhard Möckl (Department of Chemistry and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Munich, Germany), Markus Sperandio (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany), Christoph Bräuchle (Department of Chemistry and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Munich, Germany), Christoph Reichel (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany), Dagmar Zeuschner (Electron Microscopy Unit, Max Planck Institute for Molecular Biomedicine, Münster, Germany), Fritz Krombach (Walter Brendel Centre of Experimental Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany)

Kevin C. Behan (Dublin City University, School of Chemical Sciences, Glasnevin, Dublin 9), Sarah M. Martyn (Dublin City University, School of Chemical Sciences, Glasnevin, Dublin 9), Aylvin A. Dias (DSM Ahead, Urmonderbaan 22, 6167 RD Sittard-Geleen), Andreas Heise (Royal College of Surgeons, Department of Pharmaceutical and Medicinal Chemistry, 123 St. Stephen’s Green, Dublin 2), Dermot F. Brougham (University College Dublin, School of Chemistry, Stillorgan Road, Belfield, Dublin 4)

Nada Matougui (Université Angers, UMR-S1066 Angers, France), Anne Claire Groo (Normandie Univ, UNICAEN, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France), Anita Umerska (Université Angers, UMR-S1066 Angers, France), Helena Bysell (SP Technical Research Institute of Sweden), Patrick Saulnier (Université Angers, UMR-S1066 Angers, France)

Sandra Lara (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Fatima Alnasser (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Ester Polo (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), David Garry (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Maria-cristina Lo-giudice (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Delyan Hristov (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Yan Yan (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin), Kenneth A. Dawson (Centre For BioNano Interactions (CBNI), School of Chemistry and Chemical Biology, University College Dublin)

Dean Cardillo (University of Wollongong), Moeava Tehei (University of Wollongong), Md Shahriar Hossain (University of Wollongong), Md Monirul Islam (University of Wollongong), Kathrin Bogusz (University of Wollongong), Dongqi Shi (University of Wollongong), David Mitchell (University of Wollongong), Michael Lerch (University of Wollongong), Anatoly Rosenfeld (University of Wollongong), Stéphanie Corde (Prince of Wales Hospital), Konstantin Konstantinov (University of Wollongong)